BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15647345)

  • 1. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery.
    Davies DH; Liang X; Hernandez JE; Randall A; Hirst S; Mu Y; Romero KM; Nguyen TT; Kalantari-Dehaghi M; Crotty S; Baldi P; Villarreal LP; Felgner PL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):547-52. PubMed ID: 15647345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
    Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
    J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.
    Davies DH; Chun S; Hermanson G; Tucker JA; Jain A; Nakajima R; Pablo J; Felgner PL; Liang X
    J Immunol; 2014 Aug; 193(4):1812-27. PubMed ID: 25024392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.
    Ramírez M; Santos S; Martínez O; Rodríguez R; Miranda E; Ramos-Perez WD; Otero M
    Vaccine; 2018 Apr; 36(15):2049-2055. PubMed ID: 29525282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
    Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
    J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.
    Jing L; Davies DH; Chong TM; Chun S; McClurkan CL; Huang J; Story BT; Molina DM; Hirst S; Felgner PL; Koelle DM
    J Virol; 2008 Jul; 82(14):7120-34. PubMed ID: 18480455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.
    Demkowicz WE; Maa JS; Esteban M
    J Virol; 1992 Jan; 66(1):386-98. PubMed ID: 1727494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.
    Schäffner JW; Dittmer U; Otteken A; Coulibaly C; Bodemer W; Voss G; Hunsmann G
    Am J Vet Res; 1994 Sep; 55(9):1250-5. PubMed ID: 7802392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling humoral immune responses to P. falciparum infection with protein microarrays.
    Doolan DL; Mu Y; Unal B; Sundaresh S; Hirst S; Valdez C; Randall A; Molina D; Liang X; Freilich DA; Oloo JA; Blair PL; Aguiar JC; Baldi P; Davies DH; Felgner PL
    Proteomics; 2008 Nov; 8(22):4680-94. PubMed ID: 18937256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of recombinant major envelope protein (rH3L) of buffalopox virus in animal models.
    Kumar A; Yogisharadhya R; Venkatesan G; Bhanuprakash V; Shivachandra SB
    Antiviral Res; 2016 Feb; 126():108-16. PubMed ID: 26723250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
    Wang W; Huang B; Wang X; Tan W; Ruan L
    Virol Sin; 2019 Oct; 34(5):583-591. PubMed ID: 31240620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray.
    Beare PA; Chen C; Bouman T; Pablo J; Unal B; Cockrell DC; Brown WC; Barbian KD; Porcella SF; Samuel JE; Felgner PL; Heinzen RA
    Clin Vaccine Immunol; 2008 Dec; 15(12):1771-9. PubMed ID: 18845831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.